Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)

Clinical trial NCT00493129 · COMPLETED

Trial details

NCT number: NCT00493129
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Systemic Mastocytosis

Start date: 2004-07-01
Primary completion: 2007-08-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.